These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 21454913

  • 21. [New therapeutic options for smoking cessation. Nicotine polacrilex tablets for tobacco cessation].
    Noé S.
    Med Monatsschr Pharm; 2003 Dec; 26(12):418-22. PubMed ID: 14699778
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Fetuses and newborn infants exposed to Nicorette].
    Rosenberg A.
    Ugeskr Laeger; 1995 Jul 31; 157(31):4364. PubMed ID: 7645097
    [No Abstract] [Full Text] [Related]

  • 24. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
    Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, Petkova E, Rodriguez K.
    Addiction; 2007 Aug 31; 102(8):1292-302. PubMed ID: 17624979
    [Abstract] [Full Text] [Related]

  • 25. Rapid absorption of nicotine from new nicotine gum formulations.
    Shiffman S, Cone EJ, Buchhalter AR, Henningfield JE, Rohay JM, Gitchell JG, Pinney JM, Chau T.
    Pharmacol Biochem Behav; 2009 Jan 31; 91(3):380-4. PubMed ID: 18762208
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The short-term effect of nicotine chewing gum in patients with Parkinson's disease.
    Clemens P, Baron JA, Coffey D, Reeves A.
    Psychopharmacology (Berl); 1995 Jan 31; 117(2):253-6. PubMed ID: 7753975
    [Abstract] [Full Text] [Related]

  • 31. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA, Hoffmann D.
    Biomarkers; 2009 Jul 31; 14 Suppl 1():85-9. PubMed ID: 19604066
    [Abstract] [Full Text] [Related]

  • 32. Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics.
    Leischow SJ, Sachs DP, Hansen MD, Bostrom AG.
    Psychopharmacology (Berl); 1995 Jan 31; 117(2):125-9. PubMed ID: 7753957
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Are smokers trying to stop and smokers not trying to stop the same experimental model?
    Sachs DP, Benowitz N.
    NIDA Res Monogr; 1989 Jan 31; 95():366-7. PubMed ID: 2701304
    [No Abstract] [Full Text] [Related]

  • 35. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group.
    Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, Nides MA, Kiley JP.
    Chest; 1996 Feb 31; 109(2):438-45. PubMed ID: 8620719
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers.
    Sachs DP.
    Arch Intern Med; 1995 Oct 09; 155(18):1973-80. PubMed ID: 7575051
    [Abstract] [Full Text] [Related]

  • 37. Nicotine: a dependence-producing substance.
    West R.
    Prog Clin Biol Res; 1988 Oct 09; 261():237-59. PubMed ID: 3289007
    [No Abstract] [Full Text] [Related]

  • 38. Safety of nicotine-containing gum.
    Christen AG, McDonald JL.
    Prog Clin Biol Res; 1988 Oct 09; 261():219-35. PubMed ID: 3289006
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.